Neuropeptide Y (NPY) increases food intake through the action of hypothalamic NPY receptors. At least six subtypes of NPY, peptide YY (PYY), and pancreatic polypeptide (PP) receptors have been identified in mice. Although the involvement of Y1 and Y5 receptors in feeding regulation has been suggested, the relative importance of each of these NPY receptors and the participation of a novel feeding receptor are still unclear. To address this issue, we generated a Y1 receptor-deficient (Y1
food intake did not decrease to vehicle control levels. These results indicate that the Y5 receptor functions as one of the feeding receptors.
In addition, the finding that Y5-preferring agonists still induce food intake in Y5 Ϫ/Ϫ mice suggests a role for another NPY receptor(s), including the possibility of novel NPY receptors. Surprisingly, despite the limited efficacy of PYY- and PPs at the Y1 receptor, food consumption induced by these agonists was significantly diminished in Y1
Ϫ/Ϫ mice compared with that in wild-type controls. These observations suggest that the feeding stimulation induced by NPY and its analogs may be directly or indirectly modulated by the action of the Y1 receptor. We conclude that multiple NPY receptors, possibly including the novel feeding receptor, are involved in the feeding response evoked by NPY and its analogs. Among them, the Y1 receptor plays a key role in NPY-induced feeding in mice. (Endocrinology 141: [1011] [1012] [1013] [1014] [1015] [1016] 2000) N EUROPEPTIDE Y (NPY) is a highly conserved 36-amino acid peptide with potent, centrally mediated orexigenic effects (1) (2) (3) . NPY is a member of a peptide family that also includes peptide YY (PYY) and pancreatic polypeptide (PP) (1, 4) . Chronic administration of NPY into the brain results in hyperphagia and body weight gain (5, 6) . Concentrations of NPY and its messenger RNA (mRNA) in the hypothalamus are markedly increased during food deprivation and in some genetic models of obesity in rodents (7) (8) (9) (10) (11) . In addition, NPY-deficient ob/ob mice are less obese than ob/ob mice and show a reduction in food intake (12) . These data suggest that NPY is one of the major regulators of physiological feeding behavior.
Five distinct types of G protein-coupled NPY receptors, Y1, Y2, Y4, Y5, and y6, have been cloned from mice (13) . The Y5 receptor is proposed to be a feeding receptor based on the correlation between the in vitro functional and binding activities of different peptide agonists and their potent stimulation of food intake in rodent models (14) . This hypothesis was supported by the finding that intracerebroventricular (icv) administration of Y5 receptor antisense oligonucleotides reduced food intake (15, 16) . With regard to the Y1 receptors, specific Y1 antagonists suppressed feeding behaviors (17) (18) (19) , indicating that the Y1 receptor is also involved in feeding regulation. In support of a model that proposes a role for both the Y1 and Y5 receptors in food intake, a reduction of food intake induced by NPY and related peptides has been reported in Y1 receptor-deficient and Y5 receptor-deficient mice (20, 21) . However, these experiments were performed independently using genetically distinct NPY receptor-deficient mice and different NPY peptide ligands, making a head-on comparison of the effects of these ligands in each mouse strain difficult. Consequently, the performance of a direct comparative study in mice with a similar genetic background and under the same experimental conditions is crucial to evaluate the relative role of either the Y1 or the Y5 receptor in feeding regulation.
Materials and Methods Chemicals
Human NPY was purchased from Peptide Institute (Japan) and human PYY-(3-36) and PPs were obtained from Sigma (St. Louis, MO). U-50488 was obtained from RBI (Natick, MA).
Vector construction and homologous recombination
Genomic clones for mouse Y1 receptor (clone 3) and Y5 receptor (clone 17) were isolated by screening a genomic library established in FixII from TT2 embryonic stem (ES) cell DNA with a complementary DNA probe generated by a PCR strategy based on the reported nucleotide sequences of the Y1 and Y5 receptors, respectively (GenBank accession no. D63818 and AF022948). To construct the targeting vector for the Y1 receptor, a 7.5-kb 5Ј-DNA fragment spanning from the HindIII site to the end of genomic clone 3 was ligated with the pgk-neo and pgk-DT cassette constructed in Bluescript SK ϩ vector. A 1-kb BamHIClaI fragment from the 3Ј-flanking region was inserted between pgk-neo and pgk-DT to serve as a short arm. A similar strategy was employed to construct the targeting vector for the Y5 receptor. A 5-kb XbaI DNA fragment located 3Ј of the genomic clone 17 was ligated with the pgkneo-pgk-DT cassette. A 1-kb DNA fragment spanning from the EcoRV site in the 5Ј-region to the NcoI site in the first exon was inserted between pgk-neo and pgk-DT to serve as a short arm. These vectors were linearized at the NotI site located at the 3Ј-end of pgk-DT and introduced into TT2 ES cells by electroporation [C57BL/6 (B6)/CBA] as described previously (22) . After selection with G418, resistant clones were picked up, and their DNA was analyzed by PCR using a neo-specific primer PGK-R and Y1-or Y5-specific genomic primers (Y1-R5 or Y5-L2, respectively). The sequences for these primers were: PGK-R, 5Ј-CTA-AAGCGCATGCTCCAGACT-3Ј; Y1-R5, 5Ј-CCATTGCCACCTCTC-CACTCTTCTC-3Ј; and Y5-L2, 5Ј-GCTTACATCTGTAATAGAGTTC-TGAC-3Ј.
Generation of NPY receptor-deficient mice
Embryo manipulations and injection of the ES cell clones into ICR 8 cell embryos were carried out as described previously (22) . Chimeric mice with a high contribution of TT2 genetic background (monitored by agouti coat color) were bred with C57BL/6 mice. Genomic DNA was prepared from the tails of offspring for genotyping by PCR analysis. The mutant allele was detected by primers of PGK-R and Y1-R5 or Y5-L2, respectively. The PCR primers used to detect normal allele were: Y1F, 5Ј-GAACTCAACTCTGTTCTCCAAGGTTG-3Ј; Y1R, 5Ј-ATGGCGGT-GAGGTGACAGAGCAGAA-3Ј; Y5F, 5Ј-GTCTTGTTGGATCAGTG-GATGTTTGGCA-3Ј; and Y5R, 5Ј-ATCAGTATGGTCAGTCTGTA-GAAAACAC-3Ј. Northern blotting analysis of the Y1 and Y5 mRNAs in the brain was also carried out using probes generated by these primers to confirm the expression of the Y1 and Y5 transcripts.
icv peptide administration
Adult male mice (10 -12 weeks old; 25-30 g) were maintained in individual cages under controlled conditions of temperature (23 Ϯ 2 C) and light-dark cycle (0700 -1900 h). Water and pelleted food (CE-2, CLEA, Tokyo, Japan) were available ad libitum. Mice were anesthetized with sodium pentobarbital (80 mg/kg, ip; Dinabot, Tokyo, Japan). A permanent 24-gauge stainless steel cannula was stereotaxically implanted into the right lateral ventricle. The stereotaxic coordinates used were as follows: 0.4 mm posterior, 0.8 mm lateral, and 1 mm ventral to the bregma. The placement of the cannula was confirmed at the end of the experiments by injection of 0.5% Evans blue dye. Animals were allowed 1 week of recovery, and they were handled daily with mock injection to avoid nonspecific stress. Groups of 10 -40 animals received icv injections of ligands in 5 l 0.01 m PBS containing 0.05% BSA or the vehicle alone by a 30-gauge stainless steel injector that projected 1.0 mm below the tip of the cannula. Food intake experiments were performed using satiated mice with a moderate high fat diet (Oriental, Tokyo, Japan) in the beginning of the light phase to avoid the influence of indigenous peptide. Mice were fed a palatable moderate high fat diet during the dark phase before the experiments. After confirming sufficient amounts of food intake in the mice, NPY family peptides or vehicle were injected. After icv treatment, food intake was measured for a 2-h period between 0830 -1130 h.
All experimental procedures followed the Japanese Pharmacological Society Guidelines for Animal Use. Results are given as the mean Ϯ se. Statistical analysis was performed using ANOVA, followed by Bonferroni's test.
Expression of mouse receptors in COS-7 cells and receptor binding assays
The coding regions of mY1, mY2, mY4, mY5, and my6 (GenBank accession nos. Z18280, D86238, U40189, AF022948, and U58367, respectively) were cloned by PCR into the multiple cloning site of pCI-neo (Promega Corp., Madison, WI) with an optimal Kozac sequence, GC-CGCCACC, before the ATG start codons. The nucleotide sequences of the resulting clones were confirmed to be free of PCR-induced errors with an ABI 373A automated sequencer (Perkin-Elmer Corp., Norwalk, CT). DNA was transfected into COS-7 cells, membranes were prepared, binding reactions were performed, and the data were analyzed as described previously (29) , except that artificial cerebrospinal fluid (CSF) buffer (Life Technologies, Inc./BRL, Gaithersburg, MD) was used as the binding buffer. Artificial CSF buffer contained 1.5 mm CaCl 2 , 4 mm KCl, 120 mm NaCl, 1 mm MgCl 2 , and 25 mm NaHCO 3 .
Results

Generation of Y1
Ϫ/Ϫ and Y5 Ϫ/Ϫ mice
The genes encoding Y1 and Y5 receptors were individually disrupted in ES cells by homologous recombination using targeting vectors, as shown in Figs. 1A and 2A. In both cases, most of the coding exons were replaced with the neomycin resistance gene. The identity of PCR-positive ES cell clones was confirmed by Southern blotting analysis. Heterozygous lines were established from two independent ES clones for both genes (c120 and c206 for the Y1 receptor, c36 and c151 for the Y5 receptor), and these heterozygous mice were bred to generate Y1 Ϫ/Ϫ and Y5 Ϫ/Ϫ mice, respectively (Figs. 1B and 2B). Their offspring were genotyped by PCR and confirmed to lack the Y1 and Y5 receptor genes, respectively (Figs. 1C and 2C). Y1
Ϫ/Ϫ and Y5 Ϫ/Ϫ mice were live-born and had developed normally compared with the heterozygotes or wild-type littermates (knockout mice were fertile and exhibited slight obesity, as reported previously; other deficiencies/abnormalities were not noted) (20, 21) . Because the Y1 and Y5 genes are known to be located within 40 kbp, in opposite orientation on the same chromosome (23), we examined Y1
Ϫ/Ϫ and Y5 Ϫ/Ϫ mice for the expression level of the remaining intact NPY receptor. Northern blotting analysis was employed to detect the Y1 and Y5 transcripts. The Y1 transcript could not be detected in Y1 Ϫ/Ϫ mice, whereas the Y5 transcript was indistinguishable from that of wild-type mice (Fig. 1D) . Similarly, Y5 expression could not be detected in Y5
Ϫ/Ϫ mice, in which Y1 expression was indistinguishable from that in wild-type mice (Fig. 2D) . Thus, we established individual lines deficient for either the Y1 or the Y5 gene. Due to the close proximity of the Y1 and Y5 genes, it is not practical to generate a double (Y1 and Y5) knockout line by cross-breeding.
Affinity of peptide ligands at the mouse NPY receptors
Binding affinities for NPY, PYY-(3-36), human PP (hPP), bovine PP (bPP), and rat PP (rPP) were evaluated at the cloned mouse Y1, Y2, Y4, Y5, and y6 receptors expressed in COS-7 cells with pCI-neo expression vectors for each recep-tor. This evaluation helped assure that we correctly interpreted the food intake data, as affinities for these peptides have mostly been described at rat and human NPY receptors (usually using a low salt buffer). Table 1 presents the affinities of the five peptides used in the food intake studies at the cloned mouse NPY receptors. The affinities were determined in artificial CSF buffer, as the peptides were injected icv for the food intake studies. NPY has high affinities for all subtypes of NPY receptors except the Y4 receptor. PYY-(3-36) has the highest affinities for the Y2 and Y5 receptors, with reduced affinities for all remaining subtypes. PYY-(3-36) is only 3-fold less potent than NPY at the Y5 receptor, but the affinity of PYY-(3-36) at the Y1 receptor was considerably decreased (ϳ40-fold compared with that of NPY). hPP and bPP showed high affinities for both the Y4 and Y5 receptors, whereas rPP showed a high affinity for only the Y4 receptor. Only NPY and PYY-(3-36) bound to the mouse y6 receptor (8 and 24 nm, respectively) .
Effects of icv injected NPY and its analogs on feeding
Compared with the vehicle control, icv injected NPY stimulated food intake in wild-type mice (Fig. 3, A and B) . NPYinduced feeding could still be observed in Y1 Ϫ/Ϫ mice, but the magnitude of food intake was significantly reduced in Y1 Ϫ/Ϫ mice compared with that in wild-type mice (Fig. 3B) . In contrast, NPY-induced feeding was not affected in Y5 Ϫ/Ϫ mice compared with that in wild-type mice (Fig. 3B) .
Intracerebroventricular injection of PYY-(3-36) in wildtype mice evoked the most robust feeding response of any of the peptides (Fig. 3C) . PYY-(3-36)-induced feeding was significantly reduced in Y5 Ϫ/Ϫ mice. However, the remaining amount of food intake was comparable to that observed with icv NPY-induced feeding in wild-type mice (Fig. 3C) . In addition, PYY-(3-36)-induced feeding was also considerably suppressed in Y1 Ϫ/Ϫ mice compared with that in wild-type mice (Fig. 3C) .
PPs are agonists for Y4 receptors with subnanomolar bind- ing affinities (Table 1) . hPP and bPP, but not rPP, also had relatively high affinities for mouse Y5 receptors ( Table 1) . As expected from their affinities at the Y5 receptor, both hPP and bPP elicited considerable food intake, whereas rPP failed to show significant orexigenic effects in wild-type mice (Fig. 3 , D-F). hPP and bPP still induced a significant level of food intake in Y5 Ϫ/Ϫ mice, but the amount of food intake was reduced compared with that in wild-type mice (Fig. 3, D and E). Furthermore, as observed with PYY-(3-36), the ingestive behavior evoked by PPs was reduced in Y1 Ϫ/Ϫ mice even though these peptides showed low level efficacy at the Y1 receptor (based on their binding affinities; Fig. 3 , D and E, and Table 1) .
Finally, U-50488 is a potent opioid receptor agonist known to stimulate feeding behavior (24) . The robust increase in food intake in all three groups of mice after icv injection of U-50488 served as a positive control for our experimental procedures (Fig. 3G) .
Discussion
Food intake evoked by icv injected NPY was significantly reduced in Y1 Ϫ/Ϫ mice, but not in Y5 Ϫ/Ϫ mice compared with the orexigenic effect of NPY in wild-type mice. Although there seem to be some differences in the extent of feeding reduction, these data are basically in agreement with the findings of previous reports (20, 21) . However, the previous publications do not address the relative importance of the two receptor subtypes, Y1 and Y5, in feeding regulation due to differences in genetic background and experimental conditions (20, 21) . The direct comparison of Y1 Ϫ/Ϫ and Y5 Ϫ/Ϫ mice of similar genetic backgrounds studied under the same experimental conditions unquestionably demonstrates that NPY-induced feeding is predominantly mediated by the Y1 receptor rather than the Y5 receptor in mice. This key role of the Y1 receptor is also supported by previous reports that indicated that potent Y1 antagonists significantly suppressed NPY-induced feeding in rodents (17) (18) (19) .
PYY-(3-36), a potent Y2 and Y5 agonist with limited efficacy for rat Y1 receptors, is the most potent feeding stimulant after icv injection (14) . In addition, hPP and bPP, which are effective Y4 and Y5 agonists, can evoke ingestive behavior (14) . Because some Y2 and Y4 agonists fail to stimulate feeding behavior, the Y5 receptor has been considered a major feeding receptor (14, 25) . As reported previously (21), we found that the orexigenic effect of PYY-(3-36) was significantly attenuated in Y5 Ϫ/Ϫ mice compared with that in wildtype mice, although it was not abolished. Additionally, the Y5-preferring agonists, hPP and bPP, showed a tendency to induce reduced food intake in Y5 Ϫ/Ϫ mice compared with that in wild-type mice. These data suggest that the Y5 receptor is indeed involved in feeding regulation.
Interestingly, although PYY-(3-36) has no agonist activity at rat Y1 receptors (14) , we found that it has a significant affinity for mouse Y1 receptors (K i ϭ 35 nm). A similar affinity was reported for human Y1 receptors (26) . These findings suggest that a fraction of PYY-(3-36)-induced feeding observed in Y5 Ϫ/Ϫ mice might be evoked by agonism at the Y1 receptor. However, the similar orexigenic potency of PYY-(3-36) and NPY in Y5 Ϫ/Ϫ mice cannot easily be ex- The findings indicate that other subtypes of NPY receptor contribute to the feeding behavior elicited by PYY-(3-36) in Y5 Ϫ/Ϫ mice. Based on the PYY-(3-36) binding affinities, a Y2-like receptor may be involved in feeding regulation. Consistent with a role for the Y2-like receptor are reports indicating that a Y2 agonist, NPY-(13-36), induced food intake or stimulated NPY-induced feeding (19, 27) . However, a recent publication showed that icv NPY led to a similar increase in food intake in Y2
Ϫ/Ϫ and wild-type mice (28) . Thus, the typical Y2 receptor might not be involved in NPY-induced feeding. In mice, the affinity of the NPY ligands for y6 receptors has variously been reported as Y1-like, Y2-like, or Y4-like (26, 29 -31) . Thus, the y6 receptor might be a candidate for a Y2-like feeding receptor in mice. However, in rats and mice, PYY-(3-36) is the most potent feeding stimulant, even though rats (and primates) lack a functional y6 receptor (29 -31) , indicating that the y6 receptor is not an obligatory feeding receptor.
Significant food consumption induced by the Y4 and Y5 agonists, hPP and bPP, in Y5 Ϫ/Ϫ mice also suggests the participation of other feeding receptors. The Y5-preferring agonists hPP, bPP and PYY-(3-36), have different efficacy for feeding stimulation despite their similar affinities for the Y1 and Y5 receptors. These findings demonstrate that their orexigenic effects could not be explained by the action of the Y1 and Y5 receptors, especially in Y5 Ϫ/Ϫ mice. The lack of feeding stimulation by rPP in wild-type mice indicates that the typical Y4 receptor is not involved in feeding regulation. As mentioned previously, some reports showed that the y6 receptor has a Y4-like peptide affinity profile (26, 31) . However, we found no evidence for binding of the PPs to the mouse y6 receptor, indicating that the y6 receptor does not mediate any of the actions of the PPs. Taken together with the highly significant orexigenic effect of PYY-(3-36) in Y5 Ϫ/Ϫ mice, these findings suggest that novel subtypes of NPY receptors play an important role in feeding regulation.
Our data indicate that the Y1 receptor modulates the actions of other NPY receptors. This idea is supported by our finding that increased feeding induced by various peptides from the NPY family was reduced overall in Y1 Ϫ/Ϫ mice compared with that in wild-type mice. Although we cannot completely exclude a weak direct action of these ligands at the Y1 receptor, the results indicate that feeding, through the action of the other NPY receptors, including the Y5 receptor, is modulated by the Y1 receptor. A potentially synergistic involvement of both the Y1 and Y5 receptors in mediating feeding behavior is consistent with a recent report showing that neurons positive for the Y5 receptor also express the Y1 receptor in the hypothalamus (32) . It might be of interest to assess the relevance of two novel mechanisms, heterodimerization and heterologous receptor recruitment, in NPY receptor function (33, 34) . Heterodimerization of NPY receptors might contribute to the unique pharmacology of a novel feeding receptor (33) . Finally, we have to consider the possibility that developmental compensation due to the inactivation of the Y1 or Y5 receptor may have affected the functioning of the remaining NPY receptors. For example, up-regulation of Y2, Y4, and/or y6 receptors could account for the residual feeding responses observed with PYY-(3-36) and PPs in Y5 Ϫ/Ϫ mice. Experiments to evaluate receptor expression levels in the brains of NPY receptor-deficient mice are planned to further evaluate this model.
The feeding response evoked by NPY and its analogs in the wild-type, Y1 Ϫ/Ϫ , and Y5 Ϫ/Ϫ mice indicates the involvement of multiple NPY receptors, including a potentially novel feeding receptor(s). The Y1 receptor plays a critical role in NPY-induced feeding and may modulate the functioning of other NPY receptors. However, as the results presented here involve superphysiological doses of NPY ligands, additional studies are needed to characterize the role of NPY receptor subtypes under more physiologically relevant conditions. By combining the use of receptor-selective antagonists, various food intake models, and knockout mice, a clearer understanding of the role of NPY receptors will emerge.
